Why the study?
Does acetylsalicylic acid 75 mg daily reduce platelet aggregation in men with unstable coronary artery disease?
Does acetylsalicylic acid 75 mg daily reduce platelet aggregation in men with unstable coronary artery disease?
Low-dose acetylsalicylic acid (75 mg daily) provides persistent platelet inhibition over 24 months in men with unstable coronary artery disease, though a loading dose exceeding 300 mg is suggested for initial maximal inhibition.
Answers are grounded in this paper and cite their sources.
Low-dose acetylsalicylic acid inhibits platelet aggregation in unstable CAD; confirms efficacy for secondary prevention.
One-hundred-and-ninety-three men with unstable coronary artery disease (CAD) (i.e. unstable angina or a non-Q wave myocardial infarction) were randomized in a double-blind fashion to acetylsalicylic acid (ASA) 75 mg daily (n = 100) or placebo (n = 93) within 72 h of admission to the Coronary Care Unit. Platelet function was evaluated as ex vivo aggregation toward collagen and ADP before and after 5 days, 1, 12, 18 and 24 months of treatment. ASA decreased aggregation by collagen 1 mg l-1 from 81.3 +/- 1.7% before to 34.0 +/- 1.7% after 1 month (P less than 0.001), while no change was observed in the placebo group. Aggregation by ADP 1 microM after 1 month was 42.1 +/- 1.1% and 51.0 +/- 2.0% in the ASA and placebo groups respectively (P less than 0.001). The platelet inhibition by ASA was maintained during 24 months. All ASA patients had reduced aggregation during treatment. A cumulative dose of 300 mg (4 doses of 75 mg) was not enough for maximal inhibition at the second aggregation test. Thus, ASA 75 mg daily causes platelet inhibition in all patients without attenuation during long-term treatment. If low dose ASA is started in unstable coronary artery disease a loading dose exceeding 300 mg is suggested.
No takes yet. Share an insight, caveat, or question.
Berglund et al. (1991) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: